To: Jim Willie CB who wrote (10467 ) 4/2/2000 10:46:00 AM From: im a survivor Respond to of 35685
Anybody know anything about this company. A 100 - 1 forward split is fixing to commence. Currently on the pink sheets I believe, but has filed with sec.BioFiltration Systems Announces the Filing of Form 10SB/12G and a 100 for 1 Forward Split SARASOTA, Fla.--(BUSINESS WIRE)--March 16, 2000--BioFiltration Systems, Inc., symbol (Pink Sheets:BIFS) trades on the NQB Pink Sheets. It was incorporated in 1992 for the purpose of purchasing, further developing and patenting a proven Anaerobic/Aerobic Remediation Process for treating and disposing aircraft deicing and anti-icing fluids and other related organic effluent. On Feb. 3, 2000, BioFiltration Systems filed their Form 10SB/12G with the SEC in order to become a fully reporting OTC-BB stock. Refer to www.freeedgar.com to review the complete filing. BioFiltration Systems is pleased to announce a 100 for 1 Forward Split to increase the liquidity and growth potential for it's shareholders. The date of record is March 31st with an effective date of April 15th. In 1993 the company was issued US Patent no. 5,205,935 for its technology. BioFiltration Systems consists of a gifted and experienced management team. In addition the company will utilize consults and the services of some of the nations best Biochemists, and Environmental Engineers to assure it stays on the cutting edge of Technology. The acclaimed NASA/AMES Research Laboratories declared at a recent meeting of the American Association of Airport Executives (AAAE), Anaerobic bio-remediation is the most cost effective method of treating spent deicing fluids. Another study done by ARCO Chemical Company also concluded the most cost-effective method of disposal of deicing fluid was Anaerobic bio-remediation. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the Company's ability to market its products and services and future customer acceptance for these products and services and other risks detailed from time to time in company documents furnished to investors. CONTACT: BioFiltration Systems, Inc., Sarasota Toll Free: 888/246-3587 or 941/343-9300 Fax: 800/536-9379 or 941/343-0404 URL: www.biofiltrationsystems.com Email: bfs@gte.net KEYWORD: FLORIDA